Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Results presented by the LiBBY study team at the Alzheimer’s Association International Conference (“AAIC”) demonstrated statistically significant improvements in agitation symptoms compared with...
-
NEW YORK and LONDON and LEAMINGTON, Ontario, July 13, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged...
-
Organic Remedies has established an Employee Stock Ownership Plan, commonly known as ESOP. This reflects commitment to employees, patients and partners.
-
$SBEV announces licensing agreement with Argent BioPharma for CannEpil®, a proprietary, cannabinoid-based therapeutic for the treatment of epilepsy (DRE)
-
NEW YORK and TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) (“Tilray”), a global leader in medical cannabis, today announced the acquisition of HelloMD...
-
Lyphe Clinic, Tilray’s trusted medical cannabis clinic, will engage veterans, service members and families through its Lyphe for Veterans access programme. The Aldershot activation highlights Tilray...
-
MediPharm Labs announces the results of matters voted on at its annual and special meeting of shareholders held today.
-
Leafwell Publishes New PTSD Study, Builds on Evidence Supporting Medical Cannabis for Chronic Pain, Complex Chronic Conditions and Healthcare Affordability
-
Splash Beverage Group announced the completion of a CDN$300,000 strategic investment in Avicanna Inc. (TSX: AVCN)
-
NEUMÜNSTER, Germany, June 10, 2026 (GLOBE NEWSWIRE) -- Tilray Medical Germany, a division of Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) and a global leader in medical cannabis, today...